The European
Society for Medical Oncology regularly send me updates Most of them go right
over my head, but here’s an interesting one…
·
Cancer-associated thrombosis is a major health
problem that affects morbidity and mortality of people with cancer.
·
Surgical and systemic pharmacological anticancer treatments
have a significant impact on the thrombotic risk of patients.
·
Primary thromboprophylaxis may be considered in
high-risk ambulatory cancer patients using validated risk models.
·
Anticoagulant treatment of venous thromboembolism
in cancer patients is effective but may be associated with increased bleeding.
·
LMWH or DOACs are effective treatments and
generally safe options for cancer-associated thrombosis.
There’s more
on the matter which can be accessed by
clicking here.
No comments:
Post a Comment